I have previously obtained a BSc and a MSc in Molecular Biosciences at the University of Oslo. The laboratory part of my master thesis was carried out externally at the Institute of Medical Biochemistry at OUS, and the main focus was to screen for, characterize and co-crystallize inhibitors for human BCAT2. I am currently doing my PhD at the Norwegian University of Life Sciences (NMBU), in which I am a part of a large project with the aim of evolving novel carbon dioxide reducing enzymes (COOFIX).